Jim Stanker | Chief Financial Officer |
David Young | Chief Executive Officer |
Robin Garner | Craig-Hallum |
Naz Rahman | Maxim Group |
Greetings, and welcome to Processa Pharmaceuticals First Quarter 2022 Earnings Conference Call and Corporate Update. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce Jim Stanker, Chief Financial Officer.